M. Terzolo, A. Stigliano, I. Chiodini, P. Loli, L. Furlani, G. Arnaldi et al. AME position statement on adrenal incidentaloma. Eur. J. Endocrinol. 164, 851–870 (2011). https://doi.org/10.1530/EJE-10-1147

Article  CAS  PubMed  Google Scholar 

W.F. Young, The incidentally discovered adrenal mass. N. Engl. J. Med 356, 601–610 (2007). https://doi.org/10.1056/nejmcp065470

Article  CAS  PubMed  Google Scholar 

M. Fassnacht, W. Arlt, I. Bancos, H. Dralle, J. Newell-Price, A. Sahdev et al. Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors. Eur. J. Endocrinol. 175, G1–G34 (2016). https://doi.org/10.1530/EJE-16-0467

Article  CAS  PubMed  Google Scholar 

M. Araujo-Castro, M. Iturregui Guevara, M. Calatayud Gutiérrez, P. Parra Ramírez, P. Gracia Gimeno, F.A. Hanzu et al. Practical guide on the initial evaluation, follow-up, and treatment of adrenal incidentalomas Adrenal Diseases Group of the Spanish Society of Endocrinology and Nutrition. Endocrinol. Diabetes y. Nutr. 67, 408–419 (2020). https://doi.org/10.1016/j.endinu.2020.03.002

Article  Google Scholar 

J.H. Kim, Min Joo Kim, J.H. Lee, J.W. Yoon, C.S. Shin, M.J. Kim et al. Nonfunctioning adrenal incidentalomas are not clinically silent: a longitudinal cohort study. Endocr. Pr. 26, 1406–1415 (2020). https://doi.org/10.4158/EP-2020-0182

Article  Google Scholar 

F. Athanasouli, G. Georgiopoulos, N. Asonitis, F. Petychaki, A. Savelli, E. Panou et al. Nonfunctional adrenal adenomas and impaired glucose metabolism: a systematic review and meta-analysis. Endocrine 74, 50–60 (2021). https://doi.org/10.1007/s12020-021-02741-x

Article  CAS  PubMed  Google Scholar 

R. Emral, B.İ. Aydoğan, A.D. Köse, Ö. Demir, D. Çorapçıoğlu, Could a nonfunctional adrenal incidentaloma be a risk factor for increased carotid intima-media thickness and metabolic syndrome. Endocrinol. Diabetes y. Nutr. 66, 402–409 (2019). https://doi.org/10.1016/j.endinu.2019.01.007

Article  Google Scholar 

M. Araujo-Castro Cardiometabolic profile and urinary metabolomic alterations in non-functioning adrenal incidentalomas: a review. Clin Endocrinol (Oxf) (2022). https://doi.org/10.1111/cen.14745

M. Araujo-Castro, H.F. Escobar-Morreale, P. Valderrábano, A Proposal for Nomenclature Revision of Non-functioning Adrenal Incidentalomas as Adrenal Lesions of Undetermined Secretion of Adrenal Steroids (ALUSAS). Endocr Pract (2022). https://doi.org/10.1016/J.EPRAC.2022.06.007

M. Araujo-Castro, P. Parra Ramírez, C. Robles Lázaro, R. García Centeno, P. Gracia Gimeno, M.T. Fernández-Ladreda, et al. Predictors of tumour growth and autonomous cortisol secretion development during follow-up in non-functioning adrenal incidentalomas. J Clin Med 10, (2021). https://doi.org/10.3390/jcm10235509

M. Araujo-Castro, P.P. Ramírez, C.R. Lázaro, R.G. Centeno, P.G. Gimeno, M.T. Fernández-Ladreda et al. Accuracy of the dexamethasone suppression test for the prediction of autonomous cortisol secretion-related comorbidities in adrenal incidentalomas. Horm 2021 20, 1–10 (2021). https://doi.org/10.1007/S42000-021-00308-Z

Article  Google Scholar 

N. Genere, R.J. Kaur, S. Athimulam, M.A. Thomas, T. Nippoldt, M. Van Norman et al. Interpretation of abnormal dexamethasone suppression test is enhanced with use of synchronous free cortisol assessment. J. Clin. Endocrinol. Metab. 107, E1221–E1230 (2022). https://doi.org/10.1210/CLINEM/DGAB724

Article  PubMed  Google Scholar 

M. Araujo-Castro, E. Pascual-Corrales, A. Acitores Cancela, S. García Duque, L. Ley Urzaiz, V. Rodríguez Berrocal, Status and clinical and radiological predictive factors of presurgical anterior pituitary function in pituitary adenomas. Study 232 patients Endocr. 70, 584–592 (2020). https://doi.org/10.1007/s12020-020-02455-6

Article  CAS  Google Scholar 

P.A. Harris, R. Taylor, R. Thielke, J. Payne, N. Gonzalez, J.G. Conde, Research electronic data capture (REDCap)-A metadata-driven methodology and workflow process for providing translational research informatics support. J. Biomed. Inf. 42, 377–381 (2009). https://doi.org/10.1016/j.jbi.2008.08.010

Article  Google Scholar 

P.A. Harris, R. Taylor, B.L. Minor, V. Elliott, M. Fernandez, O’Neal L., et al. The REDCap consortium: Building an international community of software platform partners. J Biomed Inform 95, (2019). https://doi.org/10.1016/j.jbi.2019.103208

M. Araujo-Castro, C. Robles Lázaro, P. Parra Ramírez, R. García Centeno, P. Gracia Gimeno, M.T. Fernández-Ladreda et al. Maximum adenoma diameter, regardless of uni- or bilaterality, is a risk factor for autonomous cortisol secretion in adrenal incidentalomas. J. Endocrinol. Invest 44, 2349–2357 (2021). https://doi.org/10.1007/s40618-021-01539-y

Article  CAS  PubMed  Google Scholar 

O. Akkus, G. Akkus, O. Kaypakli, F.K. Ozturk, E. Gurkan, O. Bekler et al. Increased rates of coronary artery calcium score in patients with non - functioning adrenal incidentaloma. Endocr., Metab. Immune Disord. - Drug Targets 21, 1319–1325 (2020). https://doi.org/10.2174/1871530320666200910110337

Article  CAS  Google Scholar 

M.P. de Paula, A.B. Moraes, M. de Souza, G.C. das, E.M.R. Cavalari, R.C. Campbell, G. Fernandes, S. da et al. Cortisol level after dexamethasone suppression test in patients with non-functioning adrenal incidentaloma is positively associated with the duration of reactive hyperemia response on microvascular bed. J. Endocrinol. Invest 44, 609–619 (2021). https://doi.org/10.1007/s40618-020-01360-z

Article  CAS  PubMed  Google Scholar 

V. Morelli, C. Aresta, A. Gaudio, C. Eller-Vainicher, V.V. Zhukouskaya, D. Merlotti et al. Prediction of hypertension, diabetes and fractures in eucortisolemic women by measuring parameters of cortisol milieu. Endocrine 68, 411–419 (2020). https://doi.org/10.1007/S12020-020-02212-9

Article  CAS  PubMed  Google Scholar 

M. Parasiliti-Caprino, C. Lopez, M. Bollati, F. Bioletto, C. Sola, M.C. Di Carlo, et al. A retrospective study on the association between urine metanephrines and cardiometabolic risk in patients with nonfunctioning adrenal incidentaloma. Sci Rep 12, (2002). https://doi.org/10.1038/S41598-022-19321-2

M. Araujo-Castro, G. Casals, F.A. Hanzu, E. Pascual-Corrales, A.M. García Cano, V.F. Lanza, et al. Characterisation of the urinary steroid profile of patients with nonfunctioning adrenal incidentalomas: A matched controlled cross-sectional study. Clin Endocrinol (Oxf) 2022. https://doi.org/10.1111/CEN.14811

I. Karahan, S. Durmaz Ceylan, A. Gungunes, A. Cifci, F. Eker, U. Kisa, Non-functioning adrenal incidentalomas may increase toxic metabolites. Wien. Klin. Wochenschr. 134, 125–129 (2022). https://doi.org/10.1007/S00508-021-01909-9

Article  CAS  PubMed  Google Scholar 

M. Peppa, C. Koliaki, S.A. Raptis, Adrenal incidentalomas and cardiometabolic morbidity: an emerging association with serious clinical implications. J. Intern Med 268, 555–566 (2010). https://doi.org/10.1111/j.1365-2796.2010.02291.x

Article  CAS  PubMed  Google Scholar 

P. Falcetta, F. Orsolini, E. Benelli, P. Agretti, P. Vitti, C. Di Cosmo et al. Clinical features, risk of mass enlargement, and development of endocrine hyperfunction in patients with adrenal incidentalomas: a long-term follow-up study. Endocrine 71, 178–188 (2020). https://doi.org/10.1007/s12020-020-02476-1

Article  CAS  PubMed  PubMed Central  Google Scholar 

M. Araujo‐Castro, G. Casals, F.A. Hanzu, E. Pascual‐Corrales, A.M. García Cano, V.F. Lanza, et al. Characterisation of the urinary steroid profile of patients with nonfunctioning adrenal incidentalomas: A matched controlled cross-sectional study. Clin Endocrinol (Oxf) (2022). https://doi.org/10.1111/CEN.14811

N. Muangnoo, W. Manosroi, N. Leelathanapipat, T. Meejun, P. Chowchaiyaporn, P. Teetipsatit Predictive Factors of Functioning Adrenal Incidentaloma: A 15-Year Retrospective Study. Med 2022 58. https://doi.org/10.3390/MEDICINA58050597/S1

L. Barzon, C. Scaroni, N. Sonino, F. Fallo, A. Paoletta, M. Boscaro Risk Factors and Long-Term Follow-Up of Adrenal Incidentalomas 1. J Clin Endocrinol Metab (1999). https://doi.org/10.1210/jcem.84.2.5444

D.A. Vassiliadi, G. Ntali, E. Vicha, S. Tsagarakis, High prevalence of subclinical hypercortisolism in patients with bilateral adrenal incidentalomas: a challenge to management. Clin. Endocrinol. (Oxf.) 74, 438–444 (2011). https://doi.org/10.1111/j.1365-2265.2010.03963.x

Article  Google Scholar 

E. Vassilatou, A. Vryonidou, D. Ioannidis, S.A. Paschou, M. Panagou, I. Tzavara, Bilateral adrenal incidentalomas differ from unilateral adrenal incidentalomas in subclinical cortisol hypersecretion but not in potential clinical implications. Eur. J. Endocrinol. 171, 37–45 (2014). https://doi.org/10.1530/EJE-13-0848

Article  CAS  PubMed  Google Scholar 

H. Olsen, E. Nordenström, A. Bergenfelz, U. Nyman, S. Valdemarsson, E. Palmqvist, Subclinical hypercortisolism and CT appearance in adrenal incidentalomas: a multicenter study from Southern Sweden. Endocrine 42, 164–173 (2012). https://doi.org/10.1007/s12020-012-9622-2

Article  CAS  PubMed  Google Scholar